GHK-Cu Scalp Solution
US$ 23.59
ghk cu injection studies GHK-Cu Peptide Therapy: The Definitive Clinical Guide to Gene Modulation, Protocols, and Efficacy In Vitro and in Vivo
Description
10.1186/s12864-016-3394-7 108
This might be targeting angiogenesis and NOs cytotoxic and damaging actions but maintaining, promoting, or recovering their essential protective functions
It is not registered as a therapeutic good with the Australian TGA, the US FDA, the EMA, or any other regulatory authority worldwide
A: Typically, 50-100 mg can be administered every 4 to 6 hours as directed by a healthcare professional
